Avita Medical
Australian public company
AVH Australian Securities Exchange
ISIN AU000000AVH4 SEC CIK 1762303
Follow Avita Medical
Weekly email: filings, results
Revenue, last quarter
$26.1M
+53.1% vs same quarter last year
Net income
−$6.2M
+52.8% vs same quarter last year
EPS, diluted
−$0.20
+56.5% vs same quarter last year
Operating cash flow
−$710K
+86.4% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $71.6M | −$48.6M |
| FY24 | $64.3M | −$61.8M |
| FY23 | $50.1M | −$35.4M |
| FY22 | $34.4M | - |
| FY21 | $29.2M | - |
| FY20 | $14.3M | - |
| FY19 | $5.5M | - |
| FY18 | $929K | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 82.1% | −59.4% | −67.8% |
| FY24 | 85.8% | −88.1% | −96.3% |
| FY23 | 84.5% | −85.1% | −70.6% |
| FY22 | 82.4% | −79.9% | - |
| FY21 | 79.6% | −90.8% | - |
| FY20 | 79.2% | −299.2% | - |
| FY19 | 76.8% | −466.4% | - |
| FY18 | 41.2% | −1489.9% | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$32.2M |
| FY24 | −$58.1M |
| FY23 | −$39.4M |
| FY22 | −$19.5M |
| FY21 | −$26.8M |
| FY20 | −$23.3M |
| FY19 | −$20.3M |
| FY18 | −$13.3M |
- Avita Medical
- Healthcare median
Show the numbers
| Year | Avita Medical | Healthcare median |
|---|---|---|
| FY25 | −67.8% | −30.6% |
| FY24 | −96.3% | −47% |
| FY23 | −70.6% | −58% |
| FY22 | - | −80.4% |
| FY21 | - | −71.9% |
| FY20 | - | −62.2% |
| FY19 | - | −46.3% |
| FY18 | - | −49.6% |